Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

SELLAS Life Sciences Group Inc buy KongVestor

SELLAS Life Sciences Group Inc
Start price
€4.77
04.03.26 / 50%
Target price
-
04.03.27
Performance (%)
-4.41%
End price
€4.56
05.03.26
Summary
This prediction ended on 05.03.26 with a price of €4.56. With a performance of -4.41%, the BUY prediction for SELLAS Life Sciences Group Inc by KongVestor closed slightly in the red. KongVestor has 50% into this prediction

SELLAS Life Sciences is a clinical-stage biopharmaceutical company focused on the development of novel cancer immunotherapies for a broad range of cancer indications. The company's lead product candidate, galinpepimut-S, is a cancer immunotherapy being developed for the treatment of acute myeloid leukemia (AML) and ovarian cancer. SELLAS Life Sciences is listed on the NASDAQ stock exchange under the symbol RXII.

AI-generated
Performance without dividends (%)
Name 1w 1m
SELLAS Life Sciences Group Inc 19.910% 19.910%
iShares Core DAX® -1.283% 4.209%
iShares Nasdaq 100 -3.338% -1.744%
iShares Nikkei 225® -4.286% -1.621%
iShares S&P 500 -2.311% -0.096%

Comments by KongVestor for this prediction